Military Canine Development: New Venture Secures Major Funding for Gene-Edited Dogs

The intersection of biotechnology and defense contracting has produced a new entity designed to modernize the role of working animals in military operations. On Thursday, a startup named Warhound announced it has secured $200 million in funding to genetically engineer dogs for the United States military and outfit them with advanced protective equipment.

The venture is a collaborative effort involving Ben Lamm of Colossal Biosciences and Palmer Luckey of Anduril. According to Lamm, the company has already initiated the process of editing genes from cell samples taken from its first group of donor dogs. These biological materials were sourced from high-performing military, police, and first responder dogs across the United States. The donor pool primarily consists of Belgian Malinois, with smaller numbers of Labrador Retrievers and German Shepherds included.

The initial scientific focus is on reducing the likelihood of health issues common to these breeds, such as hip dysplasia and specific types of cancer. Scientists at Colossal are tasked with modifying the animals' genes before cloning them. While the immediate goal is health optimization, Lamm indicated to TechCrunch that further enhancements are possible. Future genetic modifications could potentially increase speed and agility or sharpen the animals' sense of smell.

The founders bring significant experience to the project. Luckey is known for founding Oculus VR and designing the Oculus Rift headset. His defense firm, Anduril, has recently won a US Army contract to build the service's next-generation battlefield intelligence system in partnership with Palantir. In 2024, Anduril also partnered with OpenAI to develop artificial intelligence for the Pentagon. Lamm’s Colossal Biosciences is recognized for its de-extinction projects, including efforts to revive the dire wolf and the woolly mammoth.

Anduril’s contribution to Warhound is centered on equipment rather than biology. The company will design the tools and software intended to protect the dogs during work. This includes gear such as goggles, vests, and body armor. The startup does not currently plan to create cyborg dogs, focusing instead on enhancing natural abilities through genetics and external protection.

The ownership structure of the company is distinct from the public profile of its founders. Although Luckey is a partner in the business, neither he nor Anduril holds a financial stake in Warhound. Colossal Biosciences does hold equity, and Lamm serves on the company's board. David Spirk, who most recently worked at Palantir, has been appointed as CEO.

Warhound expects the first batch of its genetically engineered dogs to be born in early 2027. These animals will be trained for roles already performed by working dogs, including bomb detection and search-and-rescue operations. The project represents a significant step in applying biotechnology to military support roles.